Friday, July 31, 2026

DA-1726: The New Dual-Action Obesity Treatment Set to Transform Weight Loss in 2026

MetaVia's DA-1726 obesity treatment trial approved by U.S. IRB, focusing on dual-action GLP-1 and Glucagon receptors for weight loss.

AI-Designed Proteins: How KAIST’s Breakthrough Could Revolutionize Disease Diagnosis and Drug Development

KAIST's Professor Lee Kyu Ri has designed AI-based artificial proteins for specific compound recognition, enabling advanced biosensors.

Yeonjun of TOMORROW X TOGETHER to Shine Solo on Good Morning America: What to Expect?

Yeonjun of TOMORROW X TOGETHER will perform solo on GMA's Summer Concert Series, showcasing his talent and new mini-album, "NO LABELS: PART 02."

Tag: runover

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.